Metastatic Colorectal Cancer Market Size
Market Size in USD Bn
CAGR8.3%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 8.3% |
| Market Concentration | High |
| Major Players | Amgen, Pfizer, Nurix Therapeutics Inc., Sumitomo Dainippon Pharma Oncology, Merck and Among Others |
please let us know !
Metastatic Colorectal Cancer Market Analysis
The Global Metastatic Colorectal Cancer Market is estimated to be valued at USD 10.95 billion in 2025 and is expected to reach USD 19.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032. Advances in targeted therapies and immunotherapy has led to improved clinical outcomes for metastatic colorectal cancer patients.
The market is set to witness significant growth owing to rising incidence of colorectal cancer worldwide and launch of novel targeted therapies and immunotherapies in the forecast period. Increased research and development activities for drug development by key players will also drive the market. However, complexity of cancer treatment and high cost of therapies will challenge market growth to some extent in the coming years.